Ait-hadad, Wassila
Bédard, Annabelle
Chanoine, Sébastien
Dumas, Orianne
Laouali, Nasser
Le Moual, Nicole
Leynaert, Bénédicte
Macdonald, Conor
Siroux, Valérie
Boutron-Ruault, Marie-Christine http://orcid.org/0000-0002-5956-5693
Varraso, Raphaëlle
Funding for this research was provided by:
Fondation Générale de Santé
Direction Générale de la Santé
Mission recherche de la Direction de la Recherche, des Etudes, de l’Evaluation et des Statistiques
Caisse nationale d'assurance maladie des travailleurs salariés
RSI - Sécurité Sociale Indépendants Professions Libérales
Caisse nationale de solidarité pour l'autonomie
Mutuelle Générale de l'Education Nationale
Ligue Contre le Cancer
Institut Gustave-Roussy
Agence Nationale de la Recherche (ANR-10-COHO-0006)
Article History
Received: 16 June 2021
Accepted: 19 January 2022
First Online: 27 February 2022
Declarations
:
: All authors have completed the ICMJE Form for Disclosure of Potential Conflicts of Interest. None were reported except by Dr. Chanoine who reports non-financial support from Novartis, non-financial support from Astellas, non-financial support from Boehringer Ingelheim, outside the submitted work.
: Statistical Analysis Software (SAS) were used.
: The E3N study was authorized by the French National Commission for Data Protection and Privacy (CNIL n°106.246). E3N data enrichment with the MGEN database was granted ethical approval (CCTIRS n°13.794) and was authorized by the CNIL (n°327346V14).
: All participants signed informed consent in compliance with the rules of the French National Commission for Computed Data and Individual Freedom (Commission Nationale Informatique et Libertés).
: All participants signed informed consent in compliance with the rules of the French National Commission for Computed Data and Individual Freedom (Commission Nationale Informatique et Libertés).